Neurodevelopmental Disorders

Isn’t It Time for Stricter Valproic Acid Warnings for Women of Reproductive Age?

Despite FDA warnings, valproate is still prescribed to women of reproductive age, placing children at risk for birth defects and neurodevelopmental disorders.

By |2026-01-11T12:02:35-04:00October 14th, 2025|Medications and Pregnancy, Neurodevelopmental Disorders, Pregnancy Outcomes|Comments Off on Isn’t It Time for Stricter Valproic Acid Warnings for Women of Reproductive Age?

Neurodevelopmental Outcomes in Children with Prenatal Exposure to Antiepileptic Drugs: A Systematic Review

A systematic review examines neurodevelopmental outcomes in children prenatally exposed to antiepileptic drugs.

By |2025-06-26T09:07:20-04:00May 1st, 2024|Anti-Epileptic Drugs, Neurodevelopmental Disorders, Outcomes, Pregnancy & Medications|Comments Off on Neurodevelopmental Outcomes in Children with Prenatal Exposure to Antiepileptic Drugs: A Systematic Review

Research from the CWMH: Prenatal Exposure to Second Generation Antipsychotics and Neurodevelopmental Outcomes in Preschool-Aged Children

The current study observed no significant differences in overall developmental outcomes or behavior in exposed versus unexposed children.

By |2024-06-26T12:57:54-04:00March 27th, 2024|Antipsychotic Medications, Child Outcomes, Neurodevelopmental Disorders, Outcomes, Pregnancy & Medications, Research at CWMH|Comments Off on Research from the CWMH: Prenatal Exposure to Second Generation Antipsychotics and Neurodevelopmental Outcomes in Preschool-Aged Children

Neuroimaging Study Sheds Light on the Impact of Maternal Depression and Prenatal Antidepressant Exposure on Fetal Brain Development

At 7 years of age, children exposed to maternal depression during pregnancy or SSRI antidepressants exhibited similar changes in white matter architecture.

By |2024-03-23T16:47:06-04:00February 26th, 2024|Antidepressants, Child Outcomes, Depressive Disorders, Neurodevelopmental Disorders, Pregnancy & Medications, Psychiatric Disorders During Pregnancy|Comments Off on Neuroimaging Study Sheds Light on the Impact of Maternal Depression and Prenatal Antidepressant Exposure on Fetal Brain Development

Neurodevelopmental Outcomes in Infants Exposed During Pregnancy to ADHD Medications

Prenatal exposure to ADHD medications, mostly methylphenidate, was not associated with an increased risk of neurodevelopmental disorders or growth restriction in exposed children.

By |2023-10-03T12:00:00-04:00October 11th, 2023|ADHD Medications, Neurodevelopmental Disorders, Outcomes, Pregnancy & Medications|Comments Off on Neurodevelopmental Outcomes in Infants Exposed During Pregnancy to ADHD Medications

Essential Reads: Prenatal Exposure to Benzodiazepines and Neurodevelopmental Outcomes

The largest study to date observes no increase in risk of autism or ADHD in children with prenatal exposure to benzodiazepines.

By |2022-12-09T12:49:22-04:00December 9th, 2022|Anti-Anxiety Medications, Essential Reads, Neurodevelopmental Disorders, Pregnancy & Medications|Comments Off on Essential Reads: Prenatal Exposure to Benzodiazepines and Neurodevelopmental Outcomes

Largest Study Ever Shows No Increase in Risk of Neurodevelopmental Disorders in Kids Exposed to Antidepressants In Utero

Analyzing data from nearly 150,000 children with prenatal antidepressant exposure in two healthcare databases, a recent study finds no association between prenatal exposure to antidepressants and risk for neurodevelopmental disorders.

By |2022-12-26T13:38:45-04:00October 12th, 2022|Antidepressants, Neurodevelopmental Disorders, Pregnancy & Medications, Prevalence & Risk Factors|Comments Off on Largest Study Ever Shows No Increase in Risk of Neurodevelopmental Disorders in Kids Exposed to Antidepressants In Utero

Essential Reads: Neurodevelopmental Outcomes in Children with Prenatal Exposure to Benzodiazepines and Z-Drugs

Our data regarding prenatal exposure to BZDs and/or z-drugs and risk of neurodevelopmental outcomes is still sparse.

By |2022-05-19T08:37:21-04:00May 19th, 2022|Anti-Anxiety Medications, Essential Reads, Neurodevelopmental Disorders, Pregnancy & Medications, Sleep Medications|Comments Off on Essential Reads: Neurodevelopmental Outcomes in Children with Prenatal Exposure to Benzodiazepines and Z-Drugs

Prenatal Exposure to Stress, Alterations in Fetal Brain Development Associated with Neurodevelopmental Outcomes

Fetal brain development is altered by elevated maternal distress and has adverse infant social-emotional and cognitive outcomes.

By |2022-05-19T08:26:39-04:00May 17th, 2022|Neurodevelopmental Disorders, Psychiatric Disorders During Pregnancy, PTSD and Stress Related Disorders|Comments Off on Prenatal Exposure to Stress, Alterations in Fetal Brain Development Associated with Neurodevelopmental Outcomes

Neurodevelopmental Disorders in Children Exposed to Antipsychotic Medications During Pregnancy

Prenatal exposure to antipsychotic medications was not associated with increased risk of neurodevelopmental disorders in offspring.

By |2024-04-14T16:15:33-04:00April 5th, 2022|Antipsychotic Medications, Neurodevelopmental Disorders, Outcomes, Pregnancy & Medications|Comments Off on Neurodevelopmental Disorders in Children Exposed to Antipsychotic Medications During Pregnancy
Go to Top